Fact-checked by Grok 2 weeks ago

PTS

Post-traumatic stress (PTS) is a transient psychological and physiological response to exposure to a traumatic event, encompassing symptoms such as re-experiencing the event through flashbacks or nightmares, avoidance of associated stimuli, emotional numbing, and heightened arousal including irritability and sleep disturbances.^[1] This reaction is typically adaptive, aiding immediate survival and processing, and differs from post-traumatic stress disorder (PTSD), a chronic condition defined by persistent symptoms lasting over one month that significantly impair daily functioning and require clinical intervention.^[2] Empirical data show that PTS symptoms emerge in a substantial portion of trauma survivors shortly after the event but resolve naturally in the majority without evolving into disorder.^[3] Prevalence studies reveal that PTS-like symptoms affect up to 27% of individuals one month post-trauma, declining to around 18% by three months, underscoring high natural recovery rates driven by innate resilience mechanisms rather than pathology.^[4] Risk factors for non-recovery into PTSD include trauma severity, peritraumatic dissociation, and pre-existing vulnerabilities like prior adversity or genetic predispositions, though protective elements such as social support and cognitive flexibility promote resolution.^[5] In populations like combat veterans or disaster survivors, PTS manifests acutely but highlights the distinction from long-term disability, with lifetime PTSD prevalence estimated at 3.6% among U.S. adults overall, far below total trauma exposure rates.^[6] Notable controversies include the potential overmedicalization of PTS through expanded diagnostic criteria in frameworks like DSM-5, which some analyses argue conflates normal stress responses with disorder, inflating prevalence estimates and treatment dependencies without commensurate causal evidence linking mild stressors to enduring impairment.^[7] This has prompted debates on causal realism, emphasizing empirical validation of trauma-specific pathways over broader biopsychosocial models influenced by institutional biases toward pathologizing variance in human response.^[8] Despite effective evidence-based treatments like prolonged exposure therapy for those progressing to PTSD, emphasis on spontaneous remission in PTS underscores the value of non-interventionist approaches fostering resilience over reflexive pharmacotherapy.^[9]

Definition and overview

Core symptoms and diagnostic criteria

Post-traumatic stress manifests primarily through three empirical symptom clusters: re-experiencing of the trauma, avoidance and emotional numbing, and hyperarousal. Re-experiencing symptoms include intrusive memories, flashbacks, and nightmares, which represent recurrent, involuntary recollections of the traumatic event that cause significant distress.^[7] ^[10] Neuroimaging studies consistently demonstrate amygdala hyperactivity during these episodes, correlating with heightened fear responses and impaired prefrontal regulation, as evidenced by functional MRI data showing exaggerated activation in response to trauma-related cues.^[11] ^[12] ^[13] Avoidance behaviors involve efforts to evade trauma reminders, such as places, people, or activities associated with the event, often accompanied by emotional numbing characterized by detachment or restricted affect. Longitudinal studies indicate that initial avoidance may serve adaptive functions by reducing immediate distress, but persistent patterns predict poorer long-term outcomes, with meta-analyses showing stronger associations between chronic avoidance/numbing and sustained symptom severity compared to other clusters.^[14] ^[15] ^[16] Hyperarousal encompasses heightened vigilance, irritability, exaggerated startle response, and sleep disturbances, reflecting a state of persistent physiological alertness. These symptoms are quantified in validated clinician-administered tools like the Clinician-Administered PTSD Scale (CAPS), where individual items are rated on frequency (0-4) and intensity (0-4) scales, with hyperarousal cluster scores typically ranging from 0-40; scores above 20 often indicate clinically significant impairment based on psychometric evaluations.^[17] ^[18] ^[19] Diagnosis of post-traumatic stress responses draws from symptom criteria in DSM-5 and ICD-11, requiring observable behavioral indicators—such as verifiable avoidance maneuvers or measurable startle reflexes—beyond self-reports to confirm clusters like intrusion (at least one symptom), avoidance (one each of thoughts and external cues in ICD-11), and threat hypervigilance, while emphasizing acute responses without mandating chronic duration or functional impairment for the stress construct itself.^[20] ^[21] ^[22] Post-traumatic stress (PTS) refers to the cluster of symptoms—such as intrusive memories, avoidance, hyperarousal, and negative mood alterations—that arise shortly after exposure to a traumatic event but typically resolve without intervention within days to weeks, representing an adaptive acute response rather than a pathological condition.^[23] In distinction, post-traumatic stress disorder (PTSD) is diagnosed only when these symptoms endure beyond one month post-trauma, persist with marked intensity, and substantially impair daily functioning, as specified in the DSM-5 criteria requiring exposure to actual or threatened death, serious injury, or sexual violence, followed by sustained reexperiencing, avoidance, negative cognitions, and arousal/reactivity. This temporal threshold underscores PTS as a transient phase of fear processing, often self-limiting through natural extinction mechanisms, whereas PTSD reflects failed habituation leading to chronic dysregulation.^[24] PTS also differs from acute stress disorder (ASD), which shares symptom overlap but is a formal diagnosis for dissociative and anxiety responses lasting from three days to one month post-trauma, emphasizing peritraumatic dissociation as a predictor of progression to PTSD in approximately 50% of cases; PTS, by contrast, lacks this diagnostic framing and is not tied to mandatory dissociation for identification.^[25] Unlike PTSD's chronic trajectory, where symptoms beyond three months designate a protracted form, PTS embodies the initial non-disordered cascade of stress hormones and neural activation without the enduring impairment that defines disorder status.^[26] Complex PTSD (C-PTSD), as defined in the ICD-11 for prolonged or repeated interpersonal trauma, proposes additional disturbances in self-organization (e.g., affect dysregulation, negative self-concept) beyond core PTSD symptoms, yet latent profile analyses and meta-reviews indicate insufficient empirical differentiation, with C-PTSD profiles often subsumed within severe PTSD heterogeneity rather than forming a discrete category.^[27] This lack of robust separation challenges broadening PTS into C-PTSD-like constructs absent causal validation from trauma-specific models. While PTS symptoms may overlap with those of major depressive disorder or generalized anxiety disorder—such as hypervigilance or anhedonia—their trauma etiology is demarcated by direct associative learning processes, wherein fear conditioning links trauma cues to exaggerated amygdala-mediated responses, distinguishing it from non-trauma-driven mood disorders lacking such conditioned threat generalization.^[28] This causal specificity, rooted in Pavlovian models of unextinguished fear, prioritizes trauma exposure as the precipitant over generalized vulnerability factors seen in primary anxiety conditions.^[29]

Historical development

Early observations in warfare (19th-20th century)

In the mid-19th century, during the American Civil War, physicians observed clusters of symptoms among soldiers, termed "soldier's heart" or Da Costa's syndrome, characterized by tachycardia, palpitations, anxiety, breathlessness, and fatigue following prolonged combat exposure.^[30] These manifestations, documented in over 300 cases by Union Army surgeon Jacob Mendes Da Costa, were initially attributed to organic cardiac strain from exertion and marching, rather than purely psychological factors, with symptoms persisting in some veterans post-discharge.^[31] During World War I, British forces recorded over 80,000 cases of "shell shock" by 1918, encompassing tremors, paralysis, amnesia, nightmares, and heightened startle responses among combatants subjected to artillery barrages.^[32] Initial interpretations favored physiological origins, such as micro-concussions from shell explosions disrupting neural function, evidenced by persistent motor and sensory deficits without visible injury; this view challenged Freudian attributions to hysteria or pre-existing neurosis, as frontline data showed symptom onset correlating directly with combat intensity rather than prior vulnerability.^[33] Empirical observations, including reflex hyperactivity and involuntary twitching, supported organic nervous system involvement over purely hysterical mechanisms.^[34] In World War II, termed "combat exhaustion" or "battle fatigue," symptoms like acute anxiety, insomnia, and withdrawal affected up to 40% of medical discharges in U.S. units, yet 50-70% of cases resolved sufficiently with brief rest and reassurance to permit return to duty within days, without long-term psychotherapy.^[35] Similarly, during the Korean War, forward-division treatment of battle fatigue yielded recovery in over half of cases, with many soldiers resuming combat roles after minimal intervention, indicating transient physiological exhaustion rather than inevitable chronicity.^[36] These patterns underscored that while some exhibited lingering hypervigilance and startle persistence, the majority adapted without specialized care, countering narratives of universal enduring impairment.^[37]

Post-Vietnam era and formal recognition

Following the Vietnam War, which concluded in 1975, reports of persistent psychological distress among returning veterans surged, contrasting with the acute, often self-resolving "combat fatigue" observed in prior conflicts like World War II.^[37] Media coverage and veteran advocacy groups amplified narratives of a "post-Vietnam syndrome," linking symptoms to prolonged guerrilla warfare, societal rejection upon return, and policy failures in reintegration support, thereby elevating public and congressional awareness.^[38] Longitudinal studies, such as the congressionally mandated National Vietnam Veterans Readjustment Study (NVVRS) conducted from 1984 to 1988, estimated lifetime prevalence of PTSD-like symptoms at 30.9% among male theater veterans and 26.9% among female theater veterans, with current prevalence around 15%, though reanalyses suggested lower figures of 18.7% lifetime and 9.1% current due to methodological refinements.^[39]^[40] These estimates highlighted a subset experiencing chronic impairment, yet also underscored variability influenced by combat intensity and diagnostic stringency. The push for formal recognition gained momentum through veteran-led efforts, including testimony from groups like Vietnam Veterans Against the War, which framed symptoms as a distinct disorder warranting medical and compensatory policy responses.^[41] This advocacy contributed to the inclusion of posttraumatic stress disorder (PTSD) as a new diagnostic category in the American Psychiatric Association's DSM-III in 1980, shifting emphasis from transient reactions to a potentially enduring condition triggered by extreme stressors.^[42] Critics, however, argued that the criteria lowered empirical thresholds for diagnosis by broadening stressor definitions and symptom clusters beyond prior war neurosis models, potentially conflating normal stress responses with pathology amid political pressures to validate veteran claims for benefits.^[43] The DSM-III framing prioritized chronicity, diverging from historical views of combat stress as largely remitting without intervention; data from Vietnam-era cohorts indicate that most recovery occurs spontaneously in the initial years post-exposure, with chronic cases (persisting beyond five years) comprising a minority resistant to natural remission.^[44] This evolution reflected not only empirical data but also policy incentives, such as expanded VA benefits tied to formal diagnosis, which may have incentivized reporting and sustained the chronic narrative over acute recovery patterns.^[45]

Recent diagnostic evolutions (DSM updates)

The DSM-5, published in 2013, revised PTSD criteria by consolidating the former DSM-IV Criterion A into a single, broadened exposure requirement while eliminating the A2 stipulation for intense emotional responses such as fear, helplessness, or horror.^[46] This change was justified by empirical evidence indicating that A2 added minimal predictive value for subsequent PTSD symptom development, with meta-analyses and studies showing that its absence better forecasted non-occurrence of symptoms than its presence did for full disorder onset.^[47] For instance, research demonstrated that A2 reports contributed little beyond the stressor event (A1) in forecasting PTSD-related impairments, prompting the shift toward emphasizing the event's objective severity over subjective immediacy.^[48] These alterations facilitated inclusion of diverse traumas beyond combat, such as indirect exposures (e.g., learning of family harm) or repeated professional encounters with aversive details, as evidenced in post-9/11 epidemiological studies reporting elevated PTSD rates among civilians and first responders.^[49] However, such expansions have drawn evidence-based critiques for potentially inflating prevalence through reliance on retrospective self-reports, which are prone to recall bias and overestimation; for example, 9/11 assessments often used delayed surveys susceptible to memory distortion, yielding symptom rates that exceeded prospective validations in similar cohorts.^[50]^[51] Overall prevalence shifts from DSM-IV to DSM-5 remained modest, with national estimates suggesting only slight variations rather than widespread diagnostic proliferation.^[22] In the 2020s, emerging research has advocated integrating biomarkers for more objective diagnostics, moving beyond subjective recall to measurable physiological indicators like cortisol dysregulation, where PTSD patients frequently exhibit chronically low levels reflective of HPA axis hypersensitivity.^[52] Studies, including those using hair cortisol as a cumulative stressor proxy, have identified dose-response patterns linking trauma severity to endocrine alterations, supporting calls for biomarker-augmented criteria to enhance specificity and reduce false positives from self-reported data.^[53]^[54] This trajectory aligns with broader efforts to ground PTSD evolutions in verifiable neuroendocrinological evidence, though no DSM updates have yet formalized such integrations as of 2025.^[55]

Etiology and risk factors

Traumatic events and triggers

Interpersonal traumas, particularly combat exposure and assaultive events involving physical or sexual violence, demonstrate the strongest empirical links to the development of post-traumatic stress (PTS), with evidence from longitudinal studies showing dose-response relationships where higher intensity and duration of exposure predict greater symptom severity. For instance, among military personnel, cumulative combat experiences—such as witnessing death or injury—exhibit a graded association with PTS risk, escalating from minimal exposure to multiple incidents.^[56]^[57] Similarly, assault traumas characterized by life-threatening elements, including rape or other sexual assaults, yield some of the highest conditional PTS prevalences, often exceeding 30% in affected cohorts, outperforming other trauma categories in predictive strength.^[58]^[59] Non-interpersonal traumas, such as natural disasters and accidents, are associated with lower PTS conversion rates, typically ranging from 0% to under 10% in large-scale cohort analyses, reflecting weaker causal potency absent direct interpersonal threat or intentional harm. World Mental Health Surveys across multiple countries report disaster-related PTS prevalence at 0.0–3.8% among exposed adults, with rates influenced by factors like injury but not approaching those of combat or assault.^[60] Epidemiologic reviews of disaster cohorts confirm this disparity, noting overall PTS incidence post-natural events averaging around 5% in the initial months, far below interpersonal violence benchmarks.^[61] Triggers for PTS reactivation commonly include sensory cues reminiscent of the index trauma, such as loud noises echoing combat blasts or situational reminders of assault, which elicit re-experiencing symptoms via conditioned fear responses documented in exposure-based paradigms. These triggers are most reliably linked to high-impact events with verifiable perceptual overlap, excluding unsubstantiated claims from low-severity stressors lacking dose-response validation or consistent outcome correlations in controlled studies. Minor or subjective "micro-traumas," like perceived slights without objective threat, show no robust causal evidence for inducing PTS-equivalent syndromes in population-level data.^[62]

Biological and genetic contributors

Twin studies indicate that genetic factors contribute substantially to vulnerability for post-traumatic stress symptoms, with heritability estimates ranging from 30% to 40% based on analyses of monozygotic and dizygotic twins exposed to trauma.^[63]^[64] These findings derive from large-scale veteran and civilian cohorts, highlighting polygenic influences that interact with environmental triggers rather than deterministic effects.^[65] The FKBP5 gene, which encodes a co-chaperone regulating glucocorticoid receptor sensitivity, exemplifies specific genetic contributors; polymorphisms in FKBP5, such as rs1360780, interact with childhood trauma severity to elevate risk for post-traumatic stress by prolonging stress hormone signaling.^[66]^[67] This gene-environment interaction has been replicated in diverse populations, including U.S. military personnel, where FKBP5 variants predict heightened hypothalamic-pituitary-adrenal (HPA) axis reactivity to acute stressors.^[68] HPA axis dysregulation manifests in post-traumatic stress through altered cortisol dynamics, with longitudinal assays revealing hypocortisolemia in chronic cases alongside initial hyperarousal phases post-trauma.^[69]^[70] These patterns, observed via repeated saliva and hair cortisol measurements over months to years, underscore impaired negative feedback loops that sustain vigilance but may normalize with time in resilient individuals.^[71] Neuroimaging evidence from functional MRI supports neuroplasticity in post-traumatic stress, showing reversible volumetric changes in the hippocampus and altered connectivity in fear circuits that correlate with symptom remission.^[72] Such adaptations, evident in pre- and post-exposure scans, indicate that trauma-induced alterations are not invariably fixed, as targeted interventions can restore baseline function, emphasizing inherent brain resilience mechanisms over irreversible damage.^[73]

Psychological and environmental influences

Pre-trauma personality traits, particularly high neuroticism, have been identified as significant psychological risk factors for the development of post-traumatic stress symptoms. Meta-analyses and longitudinal studies consistently show that individuals with elevated neuroticism exhibit approximately twice the odds (OR ≈ 2.0) of developing symptoms compared to those with low neuroticism, independent of trauma exposure severity.^[74] ^[75] This association persists after controlling for confounders like prior mental health, suggesting neuroticism as a predisposing factor that amplifies vulnerability through heightened emotional reactivity and poor stress regulation.^[76] Environmental influences, such as perceived social support post-trauma, correlate inversely with symptom severity in observational data, with higher support linked to reduced risk. However, causal inference remains contested due to bidirectional effects and potential reverse causation, where emerging symptoms erode social networks rather than low support causing psychopathology—a pattern supported by social erosion models and re-analyses of longitudinal cohorts.^[77] ^[78] Empirical limits are evident in twin studies, which attribute most environmental variance to unique (non-shared) experiences rather than modifiable shared contexts like family dynamics, underscoring that interventions targeting support may yield modest effects amid confounding individual differences.^[79] Cultural factors influence symptom reporting and perceived severity, with stoic orientations—prevalent in certain collectivist or high-context societies—associated with lower endorsement of distress in cross-national surveys. For instance, trauma-exposed individuals in cultures emphasizing resilience and emotional restraint, such as some Latin American or East Asian groups, report fewer intrusive or avoidant symptoms despite comparable exposure, potentially reflecting adaptive coping rather than absence of pathology.^[80] ^[81] This variability highlights reporting biases but also critiques overreliance on Western-centric diagnostic thresholds, as stoicism correlates with functional outcomes like sustained productivity, though longitudinal data on underreporting's long-term costs is limited.

Mechanisms and pathophysiology

Neurobiological changes

Trauma-related conditions such as PTS involve disruptions in the amygdala-hippocampus-prefrontal cortex circuit, where the amygdala exhibits heightened reactivity to threat cues, the hippocampus shows reduced volume and impaired contextual processing, and the prefrontal cortex demonstrates diminished inhibitory control over fear responses.^[82]^[83] These alterations arise from prolonged stress hormone exposure, particularly elevated cortisol levels, which impair synaptic plasticity and neurogenesis in the hippocampus.^[84] Prospective MRI studies of trauma survivors have identified pre-existing smaller hippocampal volumes as a risk factor for developing persistent symptoms, with further reductions observed longitudinally in those progressing to chronic states, distinguishing these changes from acute stress responses.^[85] Epigenetic modifications, including DNA methylation alterations in genes regulating stress response (e.g., FKBP5 and NR3C1), have been documented in cohorts exposed to prolonged trauma, persisting for years and correlating with symptom severity.^[86] These markers reflect heritable changes in gene expression without altering DNA sequence, driven by chronic glucocorticoid signaling that silences protective pathways.^[87] In animal models of repeated trauma, such epigenetic shifts accompany behavioral sensitization, suggesting a mechanism for the endurance of maladaptive responses beyond initial injury.^[88] Neuroplasticity in PTS manifests as a shift from adaptive to maladaptive forms, evidenced by failures in fear extinction paradigms where rodents exposed to prolonged unpredictable stress fail to suppress conditioned fear, mirroring human fMRI findings of persistent amygdala activation during extinction recall.^[82] This impairment stems from disrupted long-term potentiation in the basolateral amygdala and weakened prefrontal inputs, leading to entrenched hypervigilance rather than habituation.^[83] Chronic stress models further reveal dendritic retraction in prefrontal pyramidal neurons, reducing executive oversight and perpetuating circuit imbalance.^[84]

Cognitive and behavioral models

Behavioral models of post-traumatic stress (PTS) center on the persistence of conditioned fear responses, where trauma cues elicit automatic avoidance or arousal long after the event, akin to classical (Pavlovian) conditioning. Human laboratory studies using differential fear conditioning paradigms—pairing neutral stimuli with aversive outcomes—demonstrate that individuals with PTS show heightened acquisition of fear and significantly delayed extinction, as measured by skin conductance response or startle reflex, even when safety cues are repeatedly presented without reinforcement.^[89] ^[90] This persistence predicts testable outcomes, such as greater reinstatement of fear upon re-exposure to unsignaled threats, distinguishing PTS from resilient trauma-exposed controls in controlled settings.^[91] Cognitive models propose that maladaptive appraisals, including overestimations of threat recurrence or perceived uncontrollability of intrusive memories, sustain PTS symptoms by biasing information processing toward danger. These constructs, drawn from self-report inventories like the Posttraumatic Cognitions Inventory, correlate with symptom severity in longitudinal studies of trauma survivors, yet causal evidence remains limited to observational designs lacking experimental manipulation.^[92] ^[93] For instance, beliefs in personal fragility or permanent worldview alteration predict chronicity, but interventions targeting these appraisals show mixed specificity, suggesting they may reflect rather than drive core pathophysiology.^[94] Integrating behavioral data, models of habituation failure posit deficient inhibitory mechanisms in PTS, where repeated exposure to cues fails to reduce arousal due to impaired extinction retrieval rather than initial overlearning. Empirical support comes from conditioning tasks revealing slower habituation slopes in PTS cohorts, with physiological metrics (e.g., elevated cortisol or autonomic reactivity) persisting beyond controls, offering predictions verifiable via parametric designs varying cue intensity or context.^[95] ^[96] This contrasts with appraisal-focused theories by prioritizing measurable learning deficits over subjective interpretations, though both frameworks align on the need for data-driven tests of causality, such as prospective studies tracking pre-trauma conditioning profiles.^[97]

Diagnosis and assessment

Clinical evaluation methods

The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) serves as a gold-standard structured diagnostic interview for PTSD, assessing symptom frequency, intensity, and duration over the past month via clinician probes and behavioral anchors to minimize subjectivity.^[18] It yields both categorical diagnosis and severity scores, with administration typically lasting 45-60 minutes and requiring trained evaluators to rate responses on 0-4 scales for each of the 20 DSM-5 criteria symptoms.^[18] Inter-rater reliability exceeds 0.8, with kappa coefficients ranging from 0.78 to 0.93 across studies, supporting its objectivity in clinical settings.^[98]^[99] To enhance verification beyond self-reports, which risk inflation from recall bias or secondary incentives, physiological assessments incorporate measures like heart rate variability (HRV) and skin conductance during script-driven imagery (SDI) paradigms.^[100] In SDI, patients recount neutral and trauma-specific narratives while monitoring autonomic responses; PTSD patients typically exhibit elevated heart rate acceleration (e.g., >10 bpm) and reduced HRV (lower high-frequency components) to trauma scripts compared to controls, reflecting sympathetic hyperarousal.^[100]^[101] These objective indices correlate modestly with symptom severity (r ≈ 0.4-0.6) and aid in corroborating intrusive memory reactivity, though they are not diagnostic standalone due to individual variability.^[100] Differential diagnosis protocols emphasize multimodal scrutiny to exclude malingering, particularly in forensic or compensation-seeking contexts where prevalence may reach 10-30% per empirical reviews.^[102] Clinicians apply validity indicators such as inconsistent symptom endorsement (e.g., rare symptoms like psychogenic amnesia without corroboration), over-reporting implausible clusters via structured inventories like the Minnesota Multiphasic Personality Inventory-2 Restructured Form (MMPI-2-RF), and collateral verification from records or informants to detect fabrication.^[103] Forensic guidelines recommend integrating these with CAPS-5 probes for atypical presentations, such as exaggerated avoidance without genuine fear conditioning, ensuring diagnoses prioritize verifiable trauma exposure and impairment over unsubstantiated claims.^[104]

Challenges in verification and comorbidity

Verifying a diagnosis of post-traumatic stress (PTS) is hindered by extensive symptom overlap with comorbid conditions, particularly substance use disorders, where lifetime comorbidity rates approach 50% among affected individuals.^[105] This overlap—manifesting in shared features like hyperarousal, avoidance, and emotional dysregulation—obscures whether PTS symptoms drive substance use or vice versa, requiring multivariate regression models to isolate causal pathways amid confounding variables such as shared trauma exposure.^[106] Similar diagnostic ambiguities arise with major depressive disorder, where emotional numbing and anhedonia criteria align closely, further demanding rigorous differential assessment to avoid conflation.^[107] Retrospective self-reports, central to PTS evaluation via tools like the Clinician-Administered PTS Scale, introduce recall bias, with studies showing inconsistencies between initial and follow-up trauma narratives.^[50] Individuals with persistent PTS symptoms tend to overestimate prior severity, while those without amplify or distort peritraumatic responses over time, undermining the reliability of historical data for causal inference.^[108]^[109] Prospective ecological momentary assessments reveal discrepancies with these aggregated retrospectives, highlighting how current psychopathology distorts memory retrieval and complicates verification of symptom onset tied to specific traumas.^[110] In compensation-seeking contexts, such as U.S. Department of Veterans Affairs claims, malingering exacerbates verification challenges, with validity scales on instruments like the MMPI-2 detecting symptom exaggeration in 14-22% of evaluated cases.^[111] Forensic estimates place overall malingering base rates at 15.7% for PTS-related evaluations, often involving inflated pathology scores that diverge from genuine profiles, necessitating embedded validity measures to differentiate authentic distress from feigned impairment.^[112] These factors collectively demand multimodal verification, including collateral records and objective biomarkers where feasible, to enhance diagnostic precision amid inherent empirical hurdles.^[103]

Treatment approaches

Pharmacological interventions

Selective serotonin reuptake inhibitors (SSRIs) represent the primary class of medications with regulatory approval for post-traumatic stress disorder (PTSD), demonstrating modest efficacy in reducing core symptoms such as intrusions, avoidance, and hyperarousal based on randomized controlled trials (RCTs).^[113] Sertraline received FDA approval for PTSD treatment in 1999, marking it as the first such agent, with paroxetine following in 2001; these approvals were supported by RCTs showing statistically significant but clinically modest symptom reductions compared to placebo.^[114] Meta-analyses of SSRIs indicate small to moderate effect sizes (Cohen's d ≈ 0.3-0.5) for overall PTSD severity, with number needed to treat (NNT) estimates ranging from 4 to 7 for response rates above placebo, though benefits often wane post-discontinuation.^[115] Dropout rates in SSRI trials remain high, typically 25-30%, comparable to or slightly exceeding placebo arms, attributable to side effects including nausea, sexual dysfunction, and fatigue, which limit long-term adherence.^[116] Prazosin, an alpha-1 adrenergic antagonist, has been employed off-label to target PTSD-related nightmares and sleep disturbances by mitigating noradrenergic hyperactivity during rapid eye movement sleep.^[117] Early smaller RCTs, including Veterans Affairs (VA) studies, reported significant reductions in nightmare frequency and improved sleep quality (standardized mean difference ≈ -1.1), leading to its inclusion in some clinical guidelines despite lacking FDA approval for PTSD.^[118] However, a large multicenter VA RCT in 2018 involving 304 military veterans found no superiority over placebo for dream distress or overall sleep, prompting meta-analyses to yield mixed results with overall small effects overshadowed by heterogeneity and publication bias concerns.^[119] Side effects such as orthostatic hypotension and syncope necessitate careful titration, and the absence of long-term RCTs leaves unresolved questions about sustained efficacy and risks of tolerance or rebound symptoms.^[120] Other agents, including serotonin-norepinephrine reuptake inhibitors (SNRIs) like venlafaxine, show RCT evidence of comparable modest benefits to SSRIs but no regulatory approvals for PTSD, with similar dropout rates due to side effects like hypertension and gastrointestinal issues.^[121] Benzodiazepines lack RCT support for core PTSD symptoms and are contraindicated due to risks of dependence, tolerance, and potential exacerbation of avoidance behaviors, per systematic reviews.^[122] Overall, pharmacological interventions yield effect sizes inferior to trauma-focused psychotherapies, with high placebo responses (20-40%) in RCTs underscoring the influence of expectancy and nonspecific factors; long-term data beyond 12 weeks remain scarce, complicating recommendations for maintenance therapy.^[8]

Psychological therapies

Psychological therapies for post-traumatic stress disorder (PTSD) emphasize trauma-focused approaches, particularly variants of cognitive behavioral therapy (CBT) that incorporate exposure and cognitive restructuring, as supported by clinical guidelines and meta-analyses of randomized controlled trials.^[123] These interventions aim to modify maladaptive fear responses and cognitive distortions arising from trauma, with evidence hierarchies prioritizing therapies validated through dismantling studies that isolate active components.^[124] Prolonged exposure (PE) and cognitive processing therapy (CPT), both trauma-focused CBT protocols, demonstrate robust efficacy in reducing PTSD symptoms, outperforming waitlist controls with large effect sizes (Cohen's d ≈ 1.0–1.5) in meta-analyses spanning multiple trials.^[125]^[126] Prolonged exposure therapy involves systematic, repeated confrontation with trauma memories (imaginal exposure) and avoided real-world cues (in vivo exposure) to facilitate habituation and inhibitory learning. Meta-analytic evidence confirms PE's superiority over treatment-as-usual or waitlist conditions, with between-group effect sizes exceeding d=1.0 for PTSD symptom reduction, sustained at follow-up in many studies.^[127] However, PE exhibits notable attrition, averaging 25% across trials, attributed to the intensity of exposure evoking temporary symptom exacerbation.^[128] Dismantling research supports exposure as a core mechanism, distinguishing PE from non-exposure therapies.^[126] Eye movement desensitization and reprocessing (EMDR) pairs exposure to trauma narratives with bilateral eye movements or other dual-attention stimuli, purportedly to facilitate reprocessing. Meta-analyses indicate EMDR yields effects comparable to PE (d ≈ 0.9–1.2 versus waitlists), achieving symptom remission in similar proportions of patients.^[129] Yet, component analyses and equivalence trials suggest EMDR's benefits largely stem from its embedded exposure elements rather than bilateral stimulation, as removing eye movements does not diminish outcomes relative to standard exposure protocols.^[130] This attribution aligns with causal models emphasizing habituation over unverified working memory taxation hypotheses.^[129] Cognitive processing therapy (CPT), a CBT variant, prioritizes skill-building through identifying and challenging trauma-induced "stuck points" in beliefs about self, others, and the world, with less reliance on emotional catharsis. Meta-analyses of CPT report medium-to-large effect sizes (d ≈ 0.8–1.2) for PTSD symptom alleviation, comparable to PE, with dismantling studies confirming cognitive restructuring's independent contribution beyond exposure alone.^[131]^[124] Unlike ventilation-focused approaches, CPT's structured modules enhance long-term adaptive coping, though dropout remains a challenge across therapies, often exceeding 20% in real-world implementations.^[132] Overall, these therapies' efficacy underscores exposure and cognitive mechanisms, though individual response varies, necessitating tailored application.^[133]

Alternative and emerging methods

MDMA-assisted psychotherapy has shown promise in phase 3 clinical trials for treating severe PTSD, with participants receiving three sessions of MDMA administration combined with psychotherapy demonstrating remission rates where 67% no longer met PTSD diagnostic criteria, compared to 32% in the placebo group.^[134] These trials, conducted between 2021 and 2024, reported significant reductions in Clinician-Administered PTSD Scale (CAPS-5) scores, with 71% of MDMA-treated participants achieving loss of diagnosis at 18-week follow-up in one study.^[135] However, regulatory bodies have subjected the approach to scrutiny due to concerns over cardiovascular risks, potential for abuse, and the need for larger, long-term data to confirm durability beyond 18 weeks, despite preliminary evidence of sustained benefits in smaller cohorts up to three years post-treatment.^[136]^[137] Stellate ganglion block (SGB), a procedure targeting the sympathetic nervous system to potentially "reset" hyperarousal, has been investigated in small randomized controlled trials for rapid symptom relief in PTSD. A 2019 sham-controlled RCT with 113 active-duty service members found two SGB injections two weeks apart reduced CAPS-5 scores more than sham treatment over eight weeks, suggesting short-term efficacy in alleviating symptoms like hypervigilance.^[138] Earlier case series and smaller studies (n<50) reported quick onset of relief, but evidence is limited by modest sample sizes, lack of long-term follow-up showing sustained effects beyond a few months, and inconsistent replication across military and civilian populations.^[139] Systematic reviews emphasize that while SGB may offer adjunctive benefits for sympathetic overdrive, it does not address core cognitive or memory consolidation aspects of PTSD, warranting caution against overreliance without integration into evidence-based protocols.^[140] Mindfulness-based interventions, such as mindfulness-based stress reduction (MBSR), have been explored as alternatives for PTSD symptom management, yet randomized controlled trials and meta-analyses reveal limited trauma-specific causal mechanisms, with effects often attributable to general stress reduction rather than targeted reprocessing of traumatic memories. A 2022 meta-analysis of 10 RCTs (n=768) found MBSR yielded medium reductions in PTSD symptoms, but these were inconsistent across studies and smaller than trauma-focused therapies, lacking evidence of addressing underlying fear conditioning or avoidance patterns unique to PTSD.^[141] Critiques highlight that while mindfulness may improve comorbid anxiety or sleep in non-trauma-specific ways, RCTs show no superior causality for PTSD core symptoms compared to waitlist controls in some cases, with effect sizes diluted by high dropout rates and absence of direct trauma exposure elements.^[142] Preliminary data suggest potential as an adjunct but underscore the need for RCTs isolating trauma-focused adaptations to avoid hype over non-specific relaxation benefits.^[143]

Prognosis and recovery

Factors influencing outcomes

Longitudinal studies indicate that the timing of intervention significantly predicts recovery trajectories in post-traumatic stress (PTS). Natural remission rates are highest in the initial months post-trauma, with prevalence dropping from approximately 27% at one month to 18% at three months, suggesting a critical window for intervention before symptoms entrench.^[4] Cohorts receiving early psychological support within three months show accelerated symptom reduction compared to delayed treatment, though effects may plateau over time, emphasizing prompt access as a modifiable factor in averting chronicity.^[144] Pre-trauma and peritrauma resilience traits, such as dispositional optimism and sense of coherence, prospectively lower the odds of persistent PTS. In veteran and civilian samples tracked over years, higher baseline optimism correlates with reduced risk of new-onset symptoms post-deployment, with each unit increase in optimism linked to 11% lower odds of persistent distress.^[145] Similarly, stronger dispositional resilience yields an odds ratio of 0.95 for decreased likelihood of chronic versus remitted PTS, independent of trauma severity.^[146] These traits buffer against symptom maintenance via enhanced adaptive processing of traumatic memories. Coping strategies exert causal influence on outcomes, with avoidant styles emerging as maladaptive predictors in path models. Avoidance coping mediates the link between peritraumatic dissociation and later PTS severity, accounting for up to 20-30% of variance in symptom persistence at six weeks to years post-trauma.^[147] Longitudinal path analyses confirm that reliance on avoidance—such as thought suppression or behavioral withdrawal—positively correlates with elevated PTS scores (r ≈ 0.4-0.6), whereas approach-oriented coping fosters remission by promoting habituation.^[148] Maladaptive avoidance thus amplifies chronicity risk, underscoring the value of targeted skill-building in therapy.

Long-term impacts and resilience

Longitudinal studies indicate that a substantial proportion of individuals diagnosed with post-traumatic stress disorder (PTSD) achieve remission over extended periods, countering narratives of inevitable chronicity. In the National Vietnam Veterans Longitudinal Study (NVVLS), which tracked theater veterans from the 1980s to the 2010s, the prevalence of war-related PTSD declined by approximately half, reflecting natural recovery and remission in many cases despite persistent symptoms in others.^[149] A systematic review of adult PTSD remission rates reported 36.9% to 51.7% recovery depending on assessment timing post-trauma, with longer-term follow-ups showing sustained remission in 30-50% of cases over 10-15 years when baseline evaluations occur beyond acute phases.^[150] These outcomes highlight resilience factors such as time, social reintegration, and absence of recurrent trauma, though persistence elevates risks of comorbid conditions like depression and cardiovascular disease.^[151] Claims of post-traumatic growth (PTG)—perceived positive psychological changes following trauma—emerge frequently in self-reports, yet empirical evidence tempers enthusiasm due to methodological limitations. Meta-analyses reveal moderate correlations between PTG and adaptive factors like social support (r ≈ 0.42), but PTG often co-occurs with ongoing PTSD symptoms, suggesting it may reflect illusory optimism or retrospective reinterpretation rather than verifiable transformation.^[152] ^[153] Subgroup analyses identify patterns where PTG clusters with resilience markers, but reliance on subjective scales introduces biases, with objective behavioral or neurobiological corroboration remaining sparse.^[154] Thus, while PTG narratives promote coping, they modestly predict functional improvement beyond standard recovery trajectories. From an evolutionary standpoint, certain PTSD features, such as retained fear conditioning, may offer adaptive value in high-risk contexts by enhancing threat detection and avoidance. Fear's core role in PTSD aligns with its ancestral function of promoting survival through defensive behaviors, as evidenced in animal models where predator exposure induces enduring neural changes that heighten vigilance without full extinction.^[155] In human groups facing recurrent dangers, like military personnel or survivors in volatile environments, this hypervigilance can reduce re-victimization risks, functioning as a calibrated response rather than pure pathology.^[156] Such mechanisms underscore causal realism in PTSD's persistence: while maladaptive in safe settings, they reflect optimized responses to genuine environmental hazards, informing resilience by preserving functional caution over time.^[157]

Epidemiology and prevalence

Demographic patterns

Lifetime prevalence of post-traumatic stress disorder (PTSD) is approximately twice as high among females as males in the general U.S. population, with rates estimated at 8-10% for women and 3-5% for men based on structured diagnostic interviews.^[6] ^[158] This 2:1 ratio persists even after adjusting for trauma exposure differences, such as women's higher likelihood of experiencing sexual assault or interpersonal violence, though such factors mediate 20-30% of the gap in some models; remaining variance may reflect biological vulnerabilities, peritraumatic responses, or reporting tendencies where females endorse symptoms more readily in surveys.^[159] ^[160] PTSD prevalence is markedly elevated among military personnel and veterans relative to civilians, with lifetime estimates of 10-20% for veterans—varying by conflict exposure, such as 15-30% for post-9/11 deployers—contrasted against 5-7% in non-veteran populations per national surveys.^[5] ^[161] The National Comorbidity Survey Replication (NCS-R), a cornerstone civilian dataset, reports an overall lifetime rate of 6.8%, underscoring the exposure-driven elevation in military cohorts where combat and operational stressors amplify risk beyond baseline civilian traumas.^[6] Age-related patterns show PTSD peaking in mid-life, with lifetime prevalence around 9% in ages 45-59, compared to 6% in 18-29-year-olds and 3% in those 60 and older, largely due to accumulating lifetime trauma exposure rather than age-specific vulnerability.^[162] Cross-sectional surveys like the NCS-R highlight this gradient, though retrospective recall biases in older respondents may underestimate rates, representing a methodological artifact in age-stratified data.^[6]

Variations by trauma type and population

The conditional risk of PTSD following trauma exposure varies markedly by event type, with peritraumatic elements such as perceived threat to life or intentional harm playing a causal role in elevating vulnerability. Traumas involving interpersonal violence, including physical assault and sexual violence, exhibit the highest conditional probabilities, often ranging from 10% to over 30%, with odds ratios of 4.0 or greater relative to accidental or non-interpersonal events; for instance, rape and mugging confer risks up to 4-7 times higher than collective violence or disasters due to the betrayal and controllability deficits inherent in such experiences.^[163]^[164] In contrast, combat exposure yields intermediate risks, with conditional PTSD probabilities typically 10-20% among exposed military personnel, moderated by factors like injury severity and exposure intensity but lower than interpersonal assaults owing to preparatory training and group cohesion that buffer peritraumatic dissociation.^[163]^[165] Among occupational populations repeatedly exposed to trauma, such as first responders, PTSD prevalence is estimated at 13-18% following acute events, though rates around 15% in routine duties may be artifactually heightened by mandatory screening protocols in occupational studies, which detect elevated symptoms without full diagnostic thresholds and overlook recovery trajectories.^[166]^[167] Firefighters and paramedics, facing cumulative peritraumatic stressors like witnessing death, show symptom clusters skewed toward hyperarousal, but longitudinal data indicate that organizational support mitigates progression to chronicity compared to civilians.^[166] Cross-cultural analyses reveal lower PTSD endorsement in collectivist societies, where lifetime prevalence averages below 3% versus 5% in high-income individualistic nations, per WHO World Mental Health Surveys; this disparity stems from causal pathways emphasizing communal coping and suppressed individual rumination during peritraumatic phases, reducing symptom persistence despite comparable exposure rates.^[168] In low- and middle-income countries with stronger collectivist orientations, such as those in Asia and Latin America, peritraumatic interpretations favoring fate or social duty correlate with attenuated re-experiencing symptoms, though underreporting due to stigma may contribute.^[168]^[169]

Controversies and critiques

Debates on overdiagnosis and pathologization

Critics of PTSD diagnostic criteria argue that revisions in the DSM-5, published in 2013, have contributed to diagnostic inflation by broadening the definition of trauma and restructuring symptom clusters, leading to higher prevalence estimates in re-evaluated cohorts. For instance, analyses of existing datasets using DSM-5 rules have shown an increase in PTSD cases compared to DSM-IV, with one study reporting that the new criteria produced more diagnoses than were excluded, elevating overall rates without corresponding evidence of rising true incidence. This shift includes the removal of the requirement for an event to involve actual or threatened death, serious injury, or sexual violence (Criterion A1 in DSM-IV), allowing inclusion of indirect exposures or events eliciting horror or helplessness, which some researchers contend pathologizes adaptive stress responses rather than distinct psychopathology.^[170]^[171] The pathologization of normal grief exemplifies these concerns, as DSM-5 changes have blurred distinctions between transient bereavement reactions and chronic PTSD, particularly following traumatic losses, without prospective studies validating the expanded scope. The American Psychiatric Association's reversal of prior exclusions—analogous to the bereavement exclusion removed for major depressive disorder in the same edition—has drawn criticism for lacking empirical support that such grief routinely meets PTSD thresholds or requires intervention, potentially inflating diagnoses by conflating universal emotional responses with disorder. Re-analyses of longitudinal data indicate that symptom endorsement rises post-diagnostic expansion, but prospective validation remains absent, raising questions about whether these criteria capture genuine impairment or merely relabel normative recovery processes.^[172]^[173] Incentive structures, such as disability compensation systems, further exacerbate overdiagnosis by encouraging symptom amplification, as evidenced by discrepancies in veteran self-reports before and after filing claims. Studies of U.S. Department of Veterans Affairs claimants reveal that those seeking benefits endorse PTSD symptoms at higher rates than non-claimants or pre-filing baselines, with financial stakes—up to 100% disability ratings yielding substantial monthly payments—prompting clinicians to question report validity. For example, one investigation found that compensation-seeking veterans reported more severe symptoms during evaluations, suggesting secondary gain influences presentation, independent of trauma exposure severity. These patterns, observed across regional VA data with approval rates varying from 33% to 72% after adjustments, underscore how external rewards can drive diagnostic drift beyond clinical merit.^[174]^[175]^[176]

Efficacy of treatments and iatrogenic risks

Psychological debriefing, a single-session intervention aimed at processing trauma immediately after exposure, has demonstrated limited efficacy in preventing post-traumatic stress symptoms and may exacerbate chronicity. A 2002 meta-analysis by Rose et al., reviewing randomized controlled trials, found no evidence that debriefing reduces the incidence of PTSD or psychological distress post-trauma, with participants receiving individual debriefing showing a higher likelihood of PTSD symptoms at 13-month follow-up (odds ratio 2.49, 95% CI 1.10-5.61) compared to controls.^[177] Subsequent evaluations, including Cochrane updates, reinforce that debriefing fails to mitigate long-term morbidity and can iatrogenically prolong symptom fixation by encouraging premature rumination on traumatic details without therapeutic structure.^[178] Broader psychotherapeutic interventions for established post-traumatic stress exhibit variable outcomes, with meta-analyses highlighting null or marginal superiority over waitlist controls in certain contexts, particularly milder cases. For instance, non-trauma-focused approaches like present-centered therapy often fail to demonstrate inferiority to waitlist conditions at short-term follow-up, suggesting that expectancy effects or natural recovery may account for gains rather than specific mechanisms, while risking iatrogenic reinforcement of avoidance or rumination through unstructured discussion.^[179] Trauma-focused cognitive behavioral therapies show moderate effect sizes against passive controls in aggregated reviews (Hedges' g ≈ 1.0-1.5), but long-term persistence is inconsistent, and dropout rates of 20-30% indicate potential harm from symptom exacerbation during exposure.^[180] These patterns imply that interventions without rigorous trauma processing may inadvertently sustain distress by amplifying cognitive rehearsal without resolution, as evidenced by null findings in subgroup analyses of low-severity cohorts. Pharmacological treatments, primarily selective serotonin reuptake inhibitors like sertraline and paroxetine, yield response rates of 50-60% in trials, but placebo arms consistently achieve 30-40% improvement, undermining claims of treatment-specific causality and highlighting non-specific factors such as therapeutic alliance or regression to the mean.^[181] Meta-analyses of antidepressants report small to moderate effects (standardized mean difference ≈ 0.3-0.5) over placebo at 12 weeks, yet remission rates remain below 30%, with iatrogenic risks including sexual dysfunction, weight gain, and emotional numbing that may mimic or prolong blunted affect in post-traumatic stress.^[121] High placebo responsiveness, observed across clinician-rated and self-report measures, questions the incremental value of pharmacotherapy beyond supportive care, particularly given null long-term superiority in relapse prevention.^[115] Overall, these efficacy profiles underscore the need for cautious deployment of interventions, as iatrogenic harms—ranging from debriefing-induced chronicity to pharmacotherapy's adverse effects—can offset benefits in vulnerable populations.

Cultural and societal interpretations

Media portrayals of post-traumatic stress frequently emphasize chronic, severe cases, contributing to a public perception of inevitability that contrasts with empirical recovery patterns. Studies indicate that intensive exposure to trauma-related media coverage elevates acute distress and PTSD-like symptoms among non-directly affected individuals, with repetitive viewing linked to heightened psychological risk.^[182]^[183] This selective focus on enduring pathology, often in mainstream outlets prone to narrative-driven reporting over balanced data, amplifies rare non-recovery outcomes while underrepresenting the majority who exhibit transient symptoms or full remission.^[184]^[185] Societal shifts toward a "victimhood culture," characterized by heightened emphasis on personal trauma narratives, correlate with increased self-reported post-traumatic stress symptoms in population surveys. The broadening of trauma concepts in diagnostic frameworks and therapeutic discourse has fueled this trend, encouraging identity formation around victim status rather than agency or recovery.^[186] In environments where such framings dominate—often amplified by academic and media institutions with documented ideological biases toward pathologization—individuals report elevated PTS endorsement, independent of objective exposure severity.^[187] This cultural dynamic prioritizes interpretive vulnerability over causal factors like pre-trauma resilience, potentially inflating prevalence estimates through suggestibility in self-assessments.^[188] Countering these interpretations, resilience-oriented approaches in high-risk groups demonstrate that proactive skill-building mitigates PTS incidence, underscoring societal agency in outcomes. In the U.S. Army, Master Resilience Training (MRT) equips personnel with cognitive and emotional tools, with units implementing the program showing reduced rates of PTSD and related mental health issues compared to non-exposed cohorts.^[189]^[190] Such interventions, grounded in evidence-based positive psychology, challenge fatalistic cultural narratives by fostering adaptive responses pre- and post-exposure, aligning with data on innate human recovery capacities over politicized inevitability claims.^[191]^[192]

Societal and policy implications

Military and veteran contexts

Deployment to combat zones substantially elevates the risk of post-traumatic stress among U.S. military personnel, with studies indicating that deployed veterans are up to three times more likely to develop PTSD than non-deployed counterparts.^[193] Longitudinal Department of Defense research further links repeated combat exposures, such as those from multiple tours, to elevated rates of PTSD and related mental health diagnoses over subsequent years of service.^[194] For Operations Iraqi Freedom and Enduring Freedom veterans, PTSD prevalence estimates range from 11% to 20%, influenced by factors including intensity of combat and number of deployments.^[195] Pre-deployment screenings assess risk factors like prior mental health diagnoses, sleep quality, anxiety, and cognitive flexibility, which prospectively predict PTSD symptom trajectories following deployment.^[196] These evaluations identify vulnerabilities—such as pre-existing psychiatric conditions increasing perceived combat exposure risk—but do not disqualify personnel from service, as operational demands necessitate balancing individual susceptibility against unit readiness and mission requirements.^[197] Veterans Affairs (VA) care delivery for post-traumatic stress faces systemic delays, with mental health evaluations achieving the 14-day standard only 49% of the time based on performance metrics from the 2010s onward, persisting into the 2020s despite reforms.^[198] Audits and reports highlight bottlenecks in access, including extended wait times for specialized PTSD treatment, which can hinder early intervention and contribute to prolonged symptom severity.^[199] Intensive outpatient programs have shown efficacy in reducing symptoms for subsets of veterans, yet scalability remains constrained by resource allocation and provider shortages.^[200]

Legal and compensation systems

In the United States, disability compensation for post-traumatic stress disorder (PTSD) imposes substantial fiscal costs, with excess disability benefits attributable to the condition estimated at $32.3 billion annually across military and civilian populations.^[201] Econometric analyses indicate that financial incentives from such awards encourage symptom overreporting, as compensation-seeking claimants exhibit significantly higher rates of exaggerated PTSD symptoms compared to non-seeking individuals evaluated in clinical settings.^[174] Validity testing in forensic evaluations detects symptom exaggeration or malingering in approximately 15.7% of PTSD claims, underscoring moral hazard effects where secondary gain distorts self-reported severity.^[102] Workers' compensation systems for PTSD claims exhibit interstate variations tied to jurisdictional litigiousness and statutory frameworks, with states offering presumptive coverage for high-risk occupations like first responders yielding higher approval and award rates.^[202] For instance, litigious states with adversarial dispute resolution processes, such as California and New York, report elevated PTSD benefit payouts relative to administrative systems in less litigious jurisdictions, per analyses of permanent partial disability compensation structures.^[203] A 2010 liberalization of Department of Veterans Affairs eligibility rules for PTSD demonstrably increased claim filings and benefit uptake, providing causal evidence of policy-driven reporting incentives without corresponding rises in underlying prevalence.^[204] Reform advocates propose integrating objective biomarkers—such as genetic risk markers or neuroimaging correlates—into diagnostic protocols for compensation eligibility to mitigate reliance on subjective symptom inventories prone to inflation.^[205]^[206] These measures aim to curb moral hazard by anchoring awards to verifiable physiological indicators, as self-report biases in incentive-laden contexts undermine allocative efficiency and strain public resources.^[103] Recent Department of Veterans Affairs rating rubric revisions similarly emphasize empirical validation to address overdiagnosis risks in benefit determinations.^[207]

References

[1]
What Are the Differences Between PTS and PTSD? - Brainline.org
Dec 9, 2013 · PTS is a common, normal, and often adaptive response to experiencing a traumatic or stressful event. Common occurrences, like car accidents, can ...
[2]
What Is the Difference Between PTS and PTSD? - Cottonwood Tucson
Jan 20, 2025 · PTS is a normal response to a traumatic or stressful event. Some people involved in a car accident or who might experience complications from a ...
[3]
Natural Recovery vs. PTSD
Most people do not have PTSD one year after a trauma, regardless of the type of trauma. After sexual assault, natural recovery or resilience is most common.Most People Do Not Have... · What Helps People Recover... · Is There Anything Else That...
[4]
Change in prevalence of post-traumatic stress disorder in the two ...
May 23, 2022 · PTSD rates in the immediate aftermath of trauma exposure decline from 27% at 1 month to 18% at 3 months post-trauma, showing significant ...
[5]
Epidemiology and Impact of PTSD - National Center for PTSD
(9) The prevalence of current PTSD according to DSM-5 was 16%, 8% and 9% for the Vietnam, near-Vietnam, and U.S. cohorts who served stateside, respectively.
[6]
Post-Traumatic Stress Disorder (PTSD)
An estimated 3.6% of U.S. adults had PTSD in the past year. · Past year prevalence of PTSD among adults was higher for females (5.2%) than for males (1.8%).
[7]
Post‐traumatic stress disorder: a state‐of‐the‐art review of evidence ...
Sep 9, 2019 · This review provides an up‐to‐date outline of the current definitions of PTSD, its known prevalence and risk factors, the main models to explain the disorder,
[8]
Post‐traumatic stress disorder: a state‐of‐the‐art review of evidence ...
Sep 9, 2019 · Abstract. Post-traumatic stress disorder (PTSD) is arguably the most common psychiatric disorder to arise after exposure to a traumatic event.
[9]
Posttraumatic Stress Disorder: Evaluation and Treatment - AAFP
... empirical support in the literature and show a ... Internet-based cognitive and behavioural therapies for post-traumatic stress disorder (PTSD) in adults.
[10]
Post-traumatic stress disorder (PTSD) - Symptoms and causes
either being part of it or witnessing it ...
[11]
Neuroimaging in post-traumatic stress disorder: a narrative review
Neuroimaging insights into PTSD Studies have demonstrated hyperactivity of the amygdala in association with anxiety disorders, positively correlating with PTSD ...
[12]
Frontiers | Mental Imagery and Post-Traumatic Stress Disorder
suggest, in line with neurocircuitry models of PTSD, that intrusive memories occur due to hyper-activation in the amygdala and insula, which is disconnected ...
[13]
Amygdala Volume Changes in Posttraumatic Stress Disorder in a ...
Thus, amygdala hyperactivity in PTSD may reflect an exaggerated response of fear circuitry and may explain PTSD symptoms, such as hypervigilance and ...
[14]
Post‐traumatic stress disorder: evolving conceptualization and ...
Jan 15, 2025 · Conspicuous emotional detachment, numbing of feeling, and avoidance of stimuli that might arouse recollection of the trauma are often present ...
[15]
A Longitudinal Test of the Bi-Directional Relations between ...
Jul 14, 2012 · The current longitudinal study examined the reciprocal associations between avoidance coping and PTSD symptom severity during and after residential PTSD ...
[16]
Longitudinal associations between pandemic post-traumatic stress ...
Feb 15, 2023 · Previous cross-sectional studies have found that three PTSD clusters; re-experience, avoiding/numbing, and hyperarousal; have different ...
[17]
[PDF] Psychometric Properties of Nine Scoring Rules for the Clinician ...
For all scoring rules that involve dichotomizing individual CAPS items, a PTSD diagnosis is derived by first dichotomizing the items, and then following the DSM.
[18]
Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
CAPS-5 total symptom severity score is calculated by summing severity scores for the 20 DSM-5 PTSD symptoms. Similarly, CAPS-5 symptom cluster ...Missing: hyperarousal | Show results with:hyperarousal
[19]
https://clinicaltrials.gov/study/NCT00855816?tab=table
[20]
DSM-5 AND ICD-11 DEFINITIONS OF POSTTRAUMATIC STRESS ...
Fourth, DSM-IV requires that symptoms continue for at least 1 month, whereas ICD-10-DCR emphasizes that symptoms begin within 6 months of the event and that ...
[21]
Post-traumatic stress disorder (PTSD) and Complex PTSD
There are three groups of symptoms that are common to both the ICD-11 and the DSM-5 criteria. These are sometimes considered to be the core symptoms of PTSD:.
[22]
PTSD and DSM-5 - PTSD: National Center for PTSD - VA.gov
Describes the DSM-5 diagnostic criteria for PTSD, which remain unchanged in DSM-5-TR, and includes an overview of revisions from DSM-IV.Missing: peer- | Show results with:peer-
[23]
Posttraumatic Stress Syndrome: What Is It? - PubMed
Readily defined as symptoms consistent with posttraumatic stress disorder (PTSD), but that occur earlier than 30 days after experiencing the traumatic event.
[24]
PTS vs. PTSD: What's the Difference? - Talkspace
Jun 9, 2022 · PTS and PTSD are characterized by similar symptoms. They can cause you to feel fear and nervousness, have nightmares, and avoid people, things, and situations.
[25]
Acute Stress Disorder - PTSD
Describes acute stress disorder (ASD), including: who is at risk, how is it assessed and treated, and how is it related to PTSD.
[26]
Post-Traumatic Stress Disorder and Acute Stress Disorder I
By convention, PTSD with symptoms lasting 1 to 3 months is designated as acute, whereas PTSD with symptoms lasting more than three months is designated as ...
[27]
Are all PTSD cases complex PTSD? Results from a latent profile ...
The aim of this study is to replicate previous works to shed light on the debate related to the distinction between PTSD and C-PTSD.
[28]
The advent of fear conditioning as an animal model of post-traumatic ...
Aug 4, 2021 · Traumatic events lead to fear conditioning and sensitization that, respectively, underly PTSD symptoms of reexperiencing and avoidance and ...
[29]
A causal model of post-traumatic stress disorder - ScienceDirect.com
PTSD is triggered by well-delineated stressors, facilitating causal brain models. •. Amygdala and dACC abnormalities confer vulnerability for increased fear ...
[30]
Historical approaches to post-combat disorders - PMC
Post-combat syndromes have arisen after all major wars over the last century, and we can predict that they will continue to appear after future conflicts.
[31]
Irritable Heart and Coping with the Trauma of War
Feb 7, 2016 · Although irritable heart included some nervous symptoms, Da Costa ... soldier's heart (both as an organ and as the symbolic emotional center).
[32]
War Psychiatry and Shell Shock - 1914-1918 Online
Dec 11, 2019 · There were over 80,000 recorded cases amongst the British armies on ... WWI: Shell Shock (British Pathé) (Article) · Yealland, Lewis R ...
[33]
War office report on 'Shell shock' - The National Archives
At the time it was believed to result from a physical injury to the nervous system during a heavy bombardment or shell attack, later it became evident that men ...
[34]
'Shell shock' Revisited: An Examination of the Case Records of the ...
Ben Shephard demonstrated that shell shock played a significant role in the British Army's ... 80 000 overall number of 'shell shock' patients). In his ...
[35]
WWII Post-Traumatic Stress | New Orleans
Jun 27, 2020 · Most responded positively to the treatment and 50 to 70 percent of combat exhaustion cases were returned to combat within three days. More ...Missing: resolution intervention
[36]
Aging and Trauma: Post Traumatic Stress Disorder Among Korean ...
Combat fatigue was generally viewed as a transient condition.–. Although now octo- and nonagenarians, in 2019 there are 1.2 million living Korean War veterans ...
[37]
History of PTSD in Veterans: Civil War to DSM-5
Up to half of World War II military discharges were said to be the result of combat exhaustion. ... symptoms from traumatic events such as disaster or combat.
[38]
The Emergence of PTSD: From Post-Vietnam Syndrome to DSM ...
Jul 3, 2025 · This inclusion was driven by multidisciplinary research involving Vietnam veterans, Holocaust survivors, and survivors of sexual violence and ...
[39]
Can we solve the mysteries of the National Vietnam Veterans ...
The National Vietnam Veterans Readjustment Study (NVVRS) researchers reported that 30.9% of all men who served in that conflict developed posttraumatic stress ...
[40]
Prevalence of Post-Traumatic Stress Disorder in Aging Vietnam-Era ...
A reanalysis of NVVRS primary data sources in 2007 reported lower PTSD estimates: 9.1% for current and 18.7% for lifetime diagnoses. Another estimate of PTSD ...
[41]
[PDF] Post-Traumatic Stress Disorder or Post-Traumatic Stress Injury
PTSD was first introduced in DSM-III in 1980, advocated by Vietnam veterans. In 2011, a US Army general requested a name change to PTSI, but the APA decided ...
[42]
[PDF] The PTSD Criterion A debate: A brief history, current status, and ...
Nov 20, 2023 · Since its introduction in the DSM-III (APA, 1980), Criterion. A has been both the foundation and most controversial aspect of the PTSD diagnosis ...
[43]
PTSD in DSM-III: a case in the politics of diagnosis and disease
Aug 6, 2025 · The PTSD diagnosis is the product of a concerted effort to reintroduce war neurosis into the official psychiatric nomenclature.
[44]
Many Vietnam veterans still suffer from PTSD decades later
Jul 22, 2015 · A case of PTSD that is chronic -- lasting more than five years after war -- is likely to persist because most spontaneous recovery occurs in the ...
[45]
Contractual Report of Findings from the National Vietnam Veterans ...
The report presents findings from the National Vietnam Veterans Readjustment Study (NVVRS). The NVVRS had three broad goals, as mandated by the Congress and ...Missing: rates | Show results with:rates
[46]
The Evolving Construct of Posttraumatic Stress Disorder (PTSD) - NIH
In the DSM-5, the diagnosis of posttraumatic stress disorder (PTSD) has undergone multiple, albeit minor, changes. These changes include shifting PTSD ...Missing: predictive | Show results with:predictive
[47]
The Utility of the A1 and A2 Criteria in the Diagnosis of PTSD - PMC
Specifically, A2 reports added little to the predictive ability of an A1 stressor, though the absence of A2 predicted the absence of PTSD-related symptoms, ...
[48]
Posttraumatic stress disorder in DSM-5: Estimates of prevalence and ...
The DSM-5 PTSD proposal also suggests removing Criterion A2 entirely. McNally (2009) argued that Criterion A2's placement alongside Criterion A1 is problematic ...Missing: distinctions | Show results with:distinctions
[49]
9/11-related PTSD among highly exposed populations - NIH
Aug 14, 2017 · Another limitation is that most studies used retrospective assessment of exposure and risk factors. This makes the information on exposure ...
[50]
Challenges in the retrospective assessment of trauma: comparing a ...
Feb 1, 2016 · Less than half of the sample who reported at least one life event on the checklist that qualified as a trauma reported a trauma experience that ...
[51]
[PDF] Longterm course of probable PTSD after the 9/11 attacks: A study in ...
Several studies indicate that 9/11 PTSD is linked to comor- bid ... Self-report of traumatic exposure is subject to recall bias. However, the ...<|separator|>
[52]
Hair cortisol levels in posttraumatic stress disorder and metabolic ...
This study provides evidence of a chronically dysregulated neuroendocrine mediated stress response in PTSD, with a clear dose-response relationship.
[53]
Cortisol response to traumatic stress to predict PTSD symptom ... - NIH
Jul 4, 2023 · Cortisol was predictive for single state, emotion-related symptoms, but not overall PTSD symptoms. Trauma paradigms shed light into the ...
[54]
Post-traumatic stress disorder and potential biomarkers: a critical ...
Dec 26, 2024 · This critical review evaluates the relevant literature related to biological markers and PTSD to identify strengths, limitations, and future directions in ...
[55]
Multi-domain potential biomarkers for post-traumatic stress disorder ...
Moreover, most studies associating objective biomarkers with PTSD have used the disorder's symptom-based diagnostics as the main outcome measure, thereby ...
[56]
Duration of Exposure and the Dose-Response Model of PTSD - NIH
A dose-response model underlies posttraumatic stress disorder (PTSD) and posits a relationship between event magnitude and clinical outcome.
[57]
The Association of Combat Exposure With Postdeployment ...
Further, this study found cumulative combat exposure score (0–3 or more) appeared to have a dose response relationship with PTSD. ... The role of sexual assault ...
[58]
Life Threat during Assaultive Trauma: Critical PTSD Risk Factors for ...
Traumatic injuries due to assault (e.g. physical attack, stabbings, gunshot wounds) carry increased risk for developing PTSD, as compared to non-interpersonal ...
[59]
Trauma and PTSD in the WHO World Mental Health Surveys
These include 4.1% of all lifetime PTSD episodes associated with physical abuse by a romantic partner, 8.6% with rape, 9.5% with other sexual assault, and ...
[60]
Post-traumatic stress disorder associated with natural and human ...
Disaster-related PTSD prevalence was 0.0–3.8% among adult (ages 18+) WMH respondents and was significantly related to high education, serious injury or death of ...
[61]
Epidemiology of Post-Traumatic Stress Disorder after Disasters
Overall, studies carried out after natural disasters report a PTSD prevalence ranging from approximately 5 percent (148) to 60 percent (140) in the first 1–2 ...Ptsd Prevalence And... · Prevalence Of Ptsd · Summary And Future Research
[62]
Prevalence of Posttraumatic Stress Disorder in Trauma-Exposed ...
The pooled PTSD prevalence was 21.5% (95% CI = 13.8%-30.4%) when using the most developmentally appropriate diagnostic algorithm that was available. When ...
[63]
Genetic approaches for the study of PTSD: Advances and challenges
Furthermore, twin studies have demonstrated that genetic risk factors may account for up to 30–40% of the heritability of PTSD (6). The recent discovery of the ...
[64]
Genetic approaches for the study of PTSD: Advances and challenges
May 10, 2017 · Furthermore, twin studies have demonstrated that genetic risk factors may account for up to 30–40% of the heritability of PTSD [6]. The recent ...
[65]
International meta-analysis of PTSD genome-wide association ...
Oct 8, 2019 · The heritability results and pattern of genetic correlations are also consistent with our initial findings and with those from twin studies.
[66]
Association of FKBP5 Polymorphisms and Childhood Abuse With ...
Mar 19, 2008 · Four SNPs of the FKBP5 gene interacted with severity of child abuse as a predictor of adult PTSD symptoms.
[67]
GxE effects of FKBP5 and traumatic life events on PTSD - NIH
Sep 21, 2018 · Twin studies have demonstrated that both genetic and environmental factors influence risk for posttraumatic stress disorder (PTSD), ...
[68]
Genetic association of FKBP5 with PTSD in US service members ...
An interaction of childhood trauma with FKBP5 (a glucocorticoid-regulated immunophilin) has been reported to be associated with PTSD in the general population.
[69]
HPA axis function and diurnal cortisol in post-traumatic stress disorder
Jun 4, 2019 · The review aimed to investigate HPA axis functionality via the diurnal profile of cortisol as it relates to PTSD.
[70]
Post traumatic stress disorder associated hypothalamic-pituitary ...
Aug 20, 2024 · This review focuses on how PTSD dysregulates the HPA axis, and further, how these alterations affect the immune system and physical health outcomes.
[71]
Longitudinal associations between hair cortisol, PTSD symptoms ...
Several studies have found evidence of altered cortisol levels in patients with posttraumatic stress disorder (PTSD). Based on these findings, it is assumed ...
[72]
Hippocampal volume recovery with real-time functional MRI ...
Mar 15, 2021 · Here, we investigated whether PTSD patients showed increased hippocampal volume as a result of left amygdala real-time fMRI neurofeedback ( ...
[73]
Neurocircuitry and neuroplasticity in PTSD. - APA PsycNet
Accumulating evidence suggests that some forms of neuroplasticity are altered in PTSD, and that these alterations are responsible for producing some aspects of ...
[74]
Neuroticism and posttraumatic stress disorder: A Mendelian ...
Sep 30, 2024 · This study employs Mendelian randomization to demonstrate that neuroticism subclusters (worry, SESA, and depressed affect) influence the risk of developing ...
[75]
Personality traits and risk of posttraumatic stress disorder among ...
Jul 12, 2022 · Neuroticism and stress were the most significant predictors of diagnostic PTSD scores among all factors investigated in this study, implying ...
[76]
The Role of Personality and Subjective Exposure Experiences in ...
Dec 8, 2017 · The neuroticism trait was a risk factor of only PTSD symptoms, and stability was its protective factor after controlling for other confounders.
[77]
A re-meta-analysis of longitudinal studies and a simulation
Nov 1, 2023 · A recent meta-analysis concluded to have found proof for both a social causation model, according to which social support protects against posttraumatic stress ...
[78]
Sources of Social Support and Trauma Recovery: Evidence for ... - NIH
Mar 29, 2024 · The social erosion theory posits that PTSD symptoms degrade social support over time via their negative impact on relationships [12]. Evidence ...
[79]
Genetic and Environmental Influences on Trauma Exposure and ...
In this study the authors examined the heritability of trauma exposure and PTSD symptoms in male and female twin pairs of nonveteran volunteers.
[80]
A Cross-Cultural Comparison of Symptom Reporting and Symptom ...
May 25, 2016 · The study demonstrated that symptom reporting and identification of symptom clusters might be influenced by cultural factors. Introduction.
[81]
The cross‐cultural validity of posttraumatic stress disorder ...
Dec 13, 2010 · Cross-cultural data on the link of trauma severity to PTSD severity and on the prevalence of PTSD help to address two main questions. First, ...
[82]
Neurobiological Features of Posttraumatic Stress Disorder (PTSD ...
Aug 18, 2022 · Hypervigilance, heightened sensitivity to stimuli perceived as threatening, reexperiencing phenomena, fear-conditioning, and the inability to ...Missing: Syndrome | Show results with:Syndrome
[83]
Neurobiology and Treatment of Posttraumatic Stress Disorder
Aug 1, 2024 · This overview summarizes and updates the core knowledge of the genetic, molecular, and neural circuit features of the neurobiology of PTSDMissing: Syndrome | Show results with:Syndrome
[84]
[PDF] Neurobiology of PTSD in Adults and Children: The Impact of Stress ...
Mar 31, 2023 · PTSD and chronic stress, therefore, can greatly affect the size and neuronal makeup of the hippocampus. In order to understand the general ...
[85]
Neurobiological Insights into Post-Traumatic Stress Disorder
There are also structural changes in the brain caused by PTSD. First, there is a negative correlation between reduced hippocampal volume and PTSD symptoms.
[86]
Invisible wounds: Suturing the gap between the neurobiology ...
These traumatic experiences often create lasting neurobiological, epigenetic, and behavioral changes, and can trigger different neuropsychiatric disorders ...Missing: Syndrome | Show results with:Syndrome
[87]
The Neurotransmission Basis of Post-Traumatic Stress Disorders by ...
This review focused on fear conditioning, which constitutes a well-developed and consolidated paradigm for the study of the neurobiological mechanisms ...
[88]
The neurobiological profile of traumatized adolescents - ScienceDirect
The effects of traumatic experience on the brain/body involves changes at nearly every level of analysis, from cellular signalling to behavioral expression. In ...Missing: Syndrome | Show results with:Syndrome
[89]
Failure of Extinction of Fear Responses in Posttraumatic Stress ...
The finding of delayed extinction of a conditioned response has previously been demonstrated in first-order conditioning studies in PTSD (5, 12) . A ...
[90]
From Pavlov to PTSD: The extinction of conditioned fear in rodents ...
In this review, we use fear conditioning and extinction studies to draw a direct line from Pavlov to PTSD and other anxiety disorders.
[91]
Conditioned Fear Associated Phenotypes as Robust ... - Frontiers
Jul 20, 2014 · Fear conditioning paradigms provide a compelling translational platform for investigating the neural underpinnings of trauma- and stressor- ...
[92]
Cognitive Approaches to Posttraumatic Stress Disorder
(1999) showed that negative appraisal of symptoms, perceived negative responses from others, and a sense of having been permanently changed, all predict poor ...
[93]
Development of the Interpretation Bias Index for PTSD - PMC
Cognitive models of posttraumatic stress disorder (PTSD) implicate interpretation biases as a maintaining factor of symptoms.Missing: perceived | Show results with:perceived
[94]
Perfectionism and Perceived Control in Posttraumatic Stress ...
May 26, 2020 · In this study, we sought to examine associations between dimensions of trait perfectionism and posttraumatic stress disorder (PTSD) symptoms.Abstract · Testing The Dsm-5 New Items... · Explore Related Subjects
[95]
Learning Models of PTSD: Theoretical Accounts and ...
Such findings suggest that extinction failure in PTSD, via dominance of the acquisition memory over the extinction memory, is unlikely attributable to unduly ...
[96]
Learning Models of PTSD - Oxford Academic - Oxford University Press
That is, PTSD may be more associated with delayed extinction learning than overall failures to extinguish. ... The failure-to-habituate theory of PTSD ...
[97]
Impaired Contextual Modulation of Memories in PTSD: An fMRI and ...
Oct 1, 2014 · However, PTSD patients exhibited a failure to effectively recall the extinction memory in the safety context and were also unable to effectively ...
[98]
The revised Clinician-Administered PTSD scale for DSM-5 (CAPS-5 ...
CAPS-5-R PTSD diagnosis demonstrated good test-retest reliability, кs = .73-.79; excellent interrater reliability, кs = .86-.93; and good-to-excellent alternate ...
[99]
Full article: A comparison of the CAPS-5 and PCL-5 to assess PTSD ...
Jun 23, 2023 · The CAPS-5 has demonstrated internal consistency (α = 0.88), interrater reliability (kappa = 0.78), and test-retest reliability (kappa = 0.83; ...2. Method · 3. Results · 4. Discussion
[100]
Heart rate responsivity to script-driven imagery in posttraumatic ...
Psychophysiological measures were heart rate (HR) and blood pressure in combination with subjective anxiety ratings. In a randomized clinical trial, 20 of the ...Missing: HRV variability
[101]
Analysis of heart rate variability in posttraumatic stress disorder ...
PTSD patients at rest had significantly higher heart rate (HR) and lower heart rate variability values, with significantly lower HF and higher LF components.
[102]
Multimodal Approach to Identifying Malingered Posttraumatic Stress ...
The primary aim of this article is to aid clinicians in differentiating true posttraumatic stress disorder from malingered posttraumatic stress disorder.
[103]
A Systematic Approach to the Detection of False PTSD
Sep 1, 2025 · This article presents a systematic approach to help clinicians and forensic evaluators distinguish genuine PTSD from false variants of the disorder.
[104]
Chapter 8. Guidelines for Evaluation of Malingering in PTSD
The clinician who in a legal context evaluates a claimant for posttraumatic stress disorder (PTSD) must consider the possibility of malingering.Missing: studies protocols
[105]
Concurrent Treatment of Substance Use and PTSD - PMC
Using a chart review method, this study found a high prevalence (49.3 %) of alcohol use disorder among veterans with PTSD who received CPT. While veterans with ...
[106]
PTSD / substance use disorder comorbidity: Treatment options and ...
Posttraumatic stress disorder (PTSD) commonly co-occurs with substance use disorder (SUD) and is challenging to treat. We review all behavioral therapy ...
[107]
Symptom overlap in posttraumatic stress disorder and major ... - NIH
Over the past decade there has been consistent criticism of the diagnostic criteria of posttraumatic stress disorder (PTSD) because of its high comorbidity ...
[108]
Current PTSD symptomatology distorts memory for past symptoms
We found that people who were PTSD-negative at follow-up underestimated past PTSD symptom severity while people who were PTSD-positive overestimated past ...
[109]
Consistency of retrospective reports of peritraumatic responses and ...
Sep 13, 2010 · What individuals remember about how they reacted at the time of the traumatic event may also be vulnerable to memory inconsistency. In one study ...
[110]
Ecological Momentary Assessment of PTSD Symptoms Versus ...
Aug 17, 2019 · The aim of the present study was to examine the discrepancy between retrospective self-reporting of PTSD symptoms and ecological momentary assessment (EMA).Missing: inconsistency | Show results with:inconsistency
[111]
Psychological Testing and the Assessment of Malingering
May 17, 2025 · 34. Gold and Frueh35 found that either 14% or 22% of veterans referred for an evaluation for PTSD were classified as “extreme exaggerators” on ...<|separator|>
[112]
Assessing malingered posttraumatic stress disorder: A critical review
In a survey of forensic evaluators, base rates of malingering were estimated to be 15.7% for forensic clients and 7.4% in nonforensic evaluations (Rogers, ...
[113]
Clinician's Guide to Medications for PTSD
Currently, only sertraline and paroxetine are approved by the Food and Drug Administration (FDA) for PTSD. From the FDA perspective, all other medication uses ...Overview · Medication Monotherapy for... · Combination and/or Adjunctive...
[114]
Sertraline Approved for Post-Traumatic Stress Disorder - PubMed
Sertraline Approved for Post-Traumatic Stress Disorder. BMJ. 1999 Oct 23;319(7217):1089. Author. S Gottlieb. PMID: 10610144. Publication types. News. MeSH terms.Missing: FDA | Show results with:FDA
[115]
Evidence-based pharmacotherapy of post-traumatic stress disorder ...
This paper reviews evidence from randomized controlled trials (RCTs) for the efficacy of acute and long-term pharmacotherapy for PTSD, including the treatment ...
[116]
Meta-analysis of dropout rates in SSRIs versus placebo in ... - PubMed
Dropout rates were: 331 of 1111 (29.8%) among placebo arm and 513 of 1704 (30.3%) among SSRI participants. Random effects modeling showed that the dropout rates ...
[117]
Prazosin for treatment of post-traumatic stress disorder - PubMed
Prazosin has been an accepted treatment for patients with post-traumatic stress disorder (PTSD) who experience sleep disturbances, including nightmares.
[118]
The effects of prazosin on sleep disturbances in post-traumatic ...
Results: In our meta-analysis, prazosin resulted in a statistically significant improvement in nightmares (standardized mean difference (SMD) = -1.13, 95% ...
[119]
Trial of Prazosin for Post-Traumatic Stress Disorder in Military ...
Feb 7, 2018 · In this trial involving military veterans who had chronic PTSD, prazosin did not alleviate distressing dreams or improve sleep quality.
[120]
Drug used for PTSD nightmares falls short in large VA trial
Feb 8, 2018 · The drug prazosin, used widely to help ease PTSD nightmares, did no better than placebo in a large VA trial. Despite the apparent overall ...
[121]
Comparative Efficacy and Acceptability of Pharmaceutical ... - Frontiers
Discussion. Based on 78 RCTs from 66 studies, this study was the largest and latest meta-analysis of pharmacological treatments for PTSD in adults.Missing: NNT dropout
[122]
Post-traumatic Stress Disorder: A Narrative Review of ...
Sep 8, 2023 · Pharmacological treatments have shown a modest reduction in PTSD symptom severity [3]. However, given their limited success, there has been ...
[123]
Treating PTSD: A Review of Evidence-Based Psychotherapy ... - NIH
Nov 2, 2018 · Both guidelines strongly recommended use of Prolonged Exposure (PE), Cognitive Processing Therapy (CPT) and trauma-focused Cognitive Behavioral Therapy (CBT).
[124]
A Randomized Clinical Trial to Dismantle Components of Cognitive ...
The purpose of this experiment was to conduct a dismantling study of cognitive processing therapy in which the full protocol was compared with its constituent ...
[125]
[PDF] Exposure therapy for PTSD: A meta-analysis
Dec 21, 2021 · Exposure therapy showed large effects relative to waitlist and treatment-as-usual, a small effect relative to non-trauma-focused comparators and ...
[126]
[PDF] Prolonged exposure therapy for the treatment of posttraumatic stress ...
Mar 8, 2024 · Results from meta-analyses indicate that PE is associated with large between-group effect sizes compared to waitlist control conditions, medium ...
[127]
Exposure therapy for PTSD: A meta-analysis - ScienceDirect.com
Exposure therapy showed large effects relative to waitlist and treatment-as-usual. · Exposure showed small effects or no effects relative to active treatment ...
[128]
Meta-analysis of Dropout in Treatments for Post-traumatic Stress ...
We conducted a meta-analysis of dropout among active treatments in clinical trials for PTSD (42 studies; 17 direct comparisons).
[129]
Eye Movement Desensitization and Reprocessing (EMDR) Therapy
A meta-analysis conducted by Van Etten and Taylor found that EMDR was just as, if not more than, effective as exposure therapy in its ability to minimize PTSD ...
[130]
Prolonged Exposure vs Eye Movement Desensitization and ...
Jan 21, 2015 · Standard PE and EMDR protocols are effective, safe, and feasible in patients with PTSD and severe psychotic disorders, including current symptoms.
[131]
[PDF] A meta-analytic review of cognitive processing therapy with and ...
Jan 17, 2025 · The goal of the present study was to conduct a systematic review and meta-analysis of all available RCTs of CPT-C and CPT+A to investigate.
[132]
Full article: A meta-analysis of dropout from evidence-based ...
There has been well documented under-utilization of trauma-focused treatments and exposure techniques to treat PTSD despite their significant evidence-base.<|separator|>
[133]
Trauma‐focused psychotherapies for post‐traumatic stress disorder ...
Sep 2, 2021 · Meta-analytic reviews suggest similar outcomes across trauma-focused psychotherapies for adults with post-traumatic stress disorder (PTSD).
[134]
A Multi-Site Phase 3 Study of MDMA-Assisted Therapy for PTSD ...
0001). At the primary endpoint, 67% of participants in the MDMA group no longer met diagnostic criteria for PTSD, compared with 32% of participants in the ...Missing: 2021-2024 remission rates<|separator|>
[135]
MDMA and MDMA-Assisted Therapy | American Journal of Psychiatry
Dec 20, 2024 · After a course of MDMA-AT involving three MDMA administrations supported by psychotherapy, 67%–71% of individuals with PTSD no longer meet ...
[136]
[PDF] Midomafetamine-Assisted Psychotherapy for Post-Traumatic Stress ...
May 14, 2024 · The evidence base for MDMA-AP primarily comes from two Phase III clinical trials, MAPP1 and. MAPP2 that evaluated the short-term efficacy and ...
[137]
A Review of MDMA-Assisted Therapy for Posttraumatic Stress ...
This study included 20 patients with treatment-refractory PTSD symptoms and demonstrated an 80% remission rate sustained at 3 years after two or three sessions.
[138]
Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress ...
Nov 6, 2019 · 2 stellate ganglion block treatments 2 weeks apart were effective in reducing Clinician-Administered PTSD Scale for DSM-5 total symptom severity scores over 8 ...
[139]
Evidence Brief: Effectiveness of Stellate Ganglion Block for ... - NCBI
For example, it is quite common to see very encouraging results in a few case series, followed by smaller benefits or contradictory findings in subsequent RCTs.
[140]
Effectiveness of Stellate Ganglion Block for Treatment of PTSD
Stellate ganglion block (SGB) has been promoted as an add-on therapy for individuals with PTSD who have not fully responded to conventional treatments.
[141]
The efficacy of mindfulness‐based stress reduction intervention 3 for ...
Mar 6, 2022 · This meta-analysis included 10 RCTs with a total of 768 participants and examined the effect of MBSR interventions on PTSD symptoms. Following ...Missing: critiques | Show results with:critiques
[142]
Can mindfulness-based interventions reduce PTSD symptoms? An ...
Although mindfulness-based interventions (MBIs) may help reduce PTSD symptoms, efficacy results are inconsistent.
[143]
A meta-analytic investigation of the impact of mindfulness-based ...
Studies of trauma-specific mindfulness interventions will have greater effect sizes for reduced symptoms of PTSD than studies not focusing on trauma-specific ...Missing: critiques | Show results with:critiques
[144]
Early Treatment for Post-Traumatic Stress Disorder Accelerates ...
Apr 14, 2016 · NYU Langone researchers find most people with PTSD temporarily recover after early intervention, but treatment often reaches a plateau.
[145]
Predeployment Optimism and Onset of Postdeployment Pain in US ...
Feb 8, 2019 · As a continuous measure, each 1-U increase in optimism was associated with 11% lower odds of reporting any new pain after deployment, even while ...
[146]
Interrelations of resilience factors and their incremental impact for ...
Oct 23, 2023 · Again, higher levels of SOC, OR = 0.89, and dispositional resilience, OR = 0.95, were associated with a smaller likelihood of chronic compared ...Missing: chronicity odds
[147]
Avoidant Coping as a Mediator between Peritraumatic Dissociation ...
Path analysis was used to examine whether avoidant coping assessed 6-weeks following a motor vehicle accident mediated the relationship between in-hospital ...
[148]
Avoidance Coping Partially Accounts for the Relationship between ...
At the zero-order level, avoidance coping was positively correlated with trauma-related shame and both self-reported and interviewer-assessed PTSD symptoms.
[149]
Long-Term Impact of the War on Veterans' Lives Nearly 40 Years ...
This chapter finds that the rate of war-related PTSD declined by about half in the years between the NVVRS and the Longitudinal Study.
[150]
Remission from post-traumatic stress disorder in adults - PubMed
In studies with the baseline within the first five months following trauma the remission rate was 51.7% as compared to 36.9% in studies with the baseline later ...
[151]
Long-term outcomes of psychological treatment for posttraumatic ...
Longer-term outcomes for PTSD alone showed medium effects at 6–12 month of follow-up and large treatment effects compared with the control group at more than 12 ...
[152]
Social support and posttraumatic growth: A meta-analysis
Jan 1, 2023 · The meta-analysis indicates a medium positive effect size between social support and PTG in the trauma population, r = .418.
[153]
Empirically Derived Patterns of Posttraumatic Stress and Growth - NIH
This review aimed to identify commonly found subgroups of PTS and PTG, clinically relevant factors that distinguish the subgroups and to critically appraise ...
[154]
Growing through adversity: A meta-analytic and conceptual ...
Posttraumatic stress following trauma. Compared to the empirical study of PTG, research on PTSS following traumatic events has been more long-standing.
[155]
Post-traumatic stress disorder: evolutionary perspectives - PubMed
Fear is the key emotion of post-traumatic stress disorder (PTSD). Fear's evolved function is motivating survival via defensive behaviours.
[156]
Predator-induced fear causes PTSD-like changes in the brains and ...
Aug 7, 2019 · Our results demonstrate enduring effects on the brain and behaviour, meeting the criteria to be considered an animal model of PTSD – in a wild animal.
[157]
Post-Traumatic Stress Disorder: The Relationship Between the Fear ...
Jun 27, 2017 · Investigating the role of stress in PTSD has revealed that stress exposure can enhance fear learning and impair fear extinction, with associated ...
[158]
Gender differences in posttraumatic stress disorder. - APA PsycNET
The latter studies do indicate that women are 2.30 to 2.49 times more likely than men to develop lifetime PTSD after exposure to similar traumas. Hence, the ...<|separator|>
[159]
Sex Differences in Post-Traumatic Stress Disorder Risk
Women have twice the probability of developing PTSD after experiencing a traumatic event compared to men. Existing literatures have reported higher inflammation ...
[160]
Gender differences in risk of posttraumatic stress symptoms after ...
Jan 15, 2022 · Women experienced housing damages and loss of relatives more often than men, which explained ∼21% of the gender gap in PTSS after disaster.
[161]
Prevalence of post-traumatic stress disorder in the United States
In this study, the 1-year prevalence of PTSD was estimated at 6.7% among male veterans and 11.7% among female veterans, and the lifetime prevalence was ...
[162]
[PDF] PTSD and Aging
Lifetime prevalence of DSM-IV PTSD was estimated cross-sectionally to be 6% in ages 18-29, 8% in ages 30-44, 9% in ages 45-59, and 3% in ages 60 and older in ...
[163]
Trauma and PTSD in the WHO World Mental Health Surveys - NIH
Results: In total, 70.4% of respondents experienced lifetime traumas, with exposure averaging 3.2 traumas per capita. Substantial between-trauma differences ...
[164]
trauma characteristics and pre-existing psychiatric disorders
Oct 18, 2016 · Table 2 Odds ratio (ORs) for post-traumatic stress disorder (PTSD) ... traumas of interpersonal violence are most likely to result in PTSD [24].
[165]
Post-traumatic stress disorder among military personnel admitted at ...
PTSD is the most frequent mental illness among military people, with a lifetime prevalence rate of 22% (17). ... Additionally, the lifetime prevalence of PTSD is ...
[166]
Chronic occupational exposures can influence the rate of PTSD and ...
Jul 15, 2016 · Specifically, exposure to acute traumatic events is associated with ~13–18 % of first responders experiencing PTSD following events, such as ...
[167]
Global PTSD prevalence among active first responders and trends ...
1 in 12 first responders (8.3 %) have probable PTSD after responding to disasters. •. Prevalence may be increasing over time, particularly since the COVID-19 ...
[168]
Posttraumatic stress disorder in the World Mental Health Surveys - NIH
The lifetime prevalence of PTSD in the population was 3.9% with significant variation across countries: High income countries (5.0%) had twice the proportion of ...
[169]
A vulnerability paradox in the cross-national prevalence of post ...
Jan 2, 2018 · We identified a paradox whereby greater country vulnerability is associated with a decreased, rather than increased, risk of PTSD for its citizens.
[170]
Full article: Posttraumatic stress disorder according to DSM-5 and ...
The findings demonstrate that more diagnostic cases were produced with the DSM-5 diagnostic rules than were dropped resulting in an increase in PTSD rates ...Missing: overdiagnosis drift
[171]
Testing the DSM-5 New Items and Algorithm Change for the ...
Apr 22, 2024 · Findings add new concerns to the growing literature on problematic impacts of DSM-5 revisions to PTSD. Keywords: posttraumatic stress disorder, ...
[172]
Seeking Legitimacy for DSM-5: The Bereavement Exception as an ...
But even before publication, DSM-5 received a torrent of criticism—most prominently over removal of the “bereavement exclusion” for the diagnosis of major ...Missing: PTSD | Show results with:PTSD
[173]
The Debate Over Trauma in the New DSM Revision
May 30, 2024 · How we define trauma can affect what counts as traumatic and how posttraumatic stress disorder diagnoses get assigned.
[174]
Disability Compensation Seeking Among Veterans Evaluated for ...
CONCLUSIONS: This study provided further evidence that VA disability compensation incentives influence the way some veterans report their symptoms when they are ...
[175]
US Department of Veterans Affairs Disability Policies for ... - NIH
19,20 Thus, disability incentives may distort accurate clinical evaluation. Many VA clinicians doubt the sincerity of veterans' PTSD complaints, suspecting ...
[176]
[PDF] Compensation and PTSD
Before adjustment, PTSD disability claims approval rates ranged from 43% to 75% across regions. After adjustment, rates ranged from 33% to 72% (P < 0.0001). ...
[177]
Psychological debriefing for preventing post traumatic stress ...
There is no current evidence that psychological debriefing is a useful treatment for the prevention of post traumatic stress disorder after traumatic incidents.
[178]
Psychological debriefing for preventing post traumatic stress ...
Debriefing is a psychological treatment intended to reduce the psychological morbidity that arises after exposure to trauma (Hodgkinson & Stewart, cited in Rose ...
[179]
Do all psychological treatments really work the same in ... - NIH
This paper examines reasons for the discrepant conclusions of the meta-analyses: Does it matter whether treatments are trauma-focused or not, as current ...
[180]
Long-term efficacy of psychotherapy for posttraumatic stress disorder
This meta-analysis evaluated enduring effects of psychotherapy for PTSD in randomized controlled trials (RCTs) with long-term follow-ups (LTFUs) of at least six ...
[181]
Placebo Effects across Self-Report, Clinician-Rating, and Objective ...
Jun 1, 2019 · Remission rates from SSRI treatment for PTSD are typically below 30% (13). Clearly, more research and development is needed to improve PTSD ...
[182]
Media Exposure and the Risk of Post-Traumatic Stress Disorder ...
Nov 25, 2021 · Results: Overall, PTSD prevalence in the community due to exposure to TV coverage of the shooting was 3.1%. Shifting the whole population's ...Missing: rare amplification inevitability recovery
[183]
How Does Media Play into Trauma? | Psychology Today
Jun 9, 2020 · DRG: In all of these studies, we found that the more event-related media that people consumed, the higher their psychological distress. We also ...
[184]
PTSD, Mental Health Treatment and the Media – Carly Walter
Most of the mental health media coverage focuses on violence. Under 15% of mental health news articles describe treatment success and recovery from a mental ...
[185]
The PTSD Myth: How Media Narratives Create Barriers for Those ...
Mar 11, 2025 · This report analyzes the gap between public perception and clinical facts about PTSD among military populations, the role of media ...
[186]
How the Expansion of Trauma Diagnoses Fueled Victimhood Culture
Nov 27, 2024 · Exploring the DSM's evolution to the rise of trauma-informed care and the proliferation of trauma culture.
[187]
Unraveling the Mindset of Victimhood - Scientific American
Jun 29, 2020 · Vice versa, experiencing severe trauma or victimization doesn't necessarily mean that someone is going to develop a victimhood mindset.
[188]
Social, cultural, and other diversity issues in the traumatic stress field
Psychological trauma and PTSD occur across the full spectrum of gender, racial, ethnic, and cultural groups in the United States (Pole, Gone, & Kulkarni, 2008).
[189]
[PDF] COMPREHENSIVE - Army Resilience Directorate
1) Do Soldiers in units with MRT trainers experience lower rates of mental health problems (i.e., anxiety/depression/PTSD) and substance abuse problems (i.e.,.
[190]
Master Resilience Training (MRT) in the US Army (+PPT)
Master Resilience Training (MRT) is designed to build mental toughness, strengthen character & enhance performance through resilience skills.
[191]
Preventing and Mitigating Post-Traumatic Stress: A Scoping Review ...
Jun 17, 2024 · Resilience interventions, like pre-deployment programs, are believed to be effective in reducing PTSD, but no single method is best, and ...
[192]
(PDF) Master Resilience Training in the U.S. Army - ResearchGate
Oct 1, 2025 · The 10-day MRT course is the foundation for training resilience skills to sergeants and for teaching sergeants how to teach these skills to their soldiers.
[193]
How Common is PTSD in Veterans? - National Center for PTSD
PTSD is slightly more common among Veterans than civilians. At some point in their life, 7 out of every 100 Veterans (or 7%) will have PTSD.
[194]
Longitudinal Relationship of Combat Exposure With Mental Health ...
Jan 25, 2021 · Combat exposure in the first 2 years of military service was associated with significantly higher rates of a wide range of mental health diagnoses over a two- ...
[195]
Posttraumatic Stress Disorder (PTSD) - Research.va.gov
PTSD can occur after a traumatic event such as military combat, a physical assault, or a natural disaster.New, Ongoing, and Published... · Main treatments for PTSD · Other PTSD treatments
[196]
Pre-deployment risk factors for PTSD in active-duty personnel ... - NIH
Jun 2, 2020 · Soldiers are at risk for developing post-traumatic stress disorder (PTSD) and the lifetime prevalence of probable PTSD of 8% [1] is elevated ...
[197]
Effect of Predeployment Psychiatric Diagnoses on Postdeployment ...
Mar 29, 2020 · Personnel with a predeployment psychiatric diagnosis demonstrated a higher risk of reporting high levels of perceived combat exposure. Perceived ...<|separator|>
[198]
On VA's Mental Health Wait Times - VA News
The Veterans Health Administration met its goal of fully evaluating patients within 14 days only about 49 percent of the time. The remaining 51 percent waited ...
[199]
VA Outperforms Wait Times Compared to Community Care
A sizeable proportion of Veterans experienced wait times that exceeded the VA standard (20 days or less): 44% of VA appointments and 50% of community care ...
[200]
Examining the Veterans Health Administration Whole Health Model ...
Veterans with PTSD who used Whole Health services experienced small improvements over 6 months in physical (Cohen's d = .12) and mental (Cohen's d = .15) health ...
[201]
The Economic Burden of Posttraumatic Stress Disorder in the United ...
Apr 25, 2022 · Thus, the excess costs of disability benefits due to PTSD were estimated at $32.3 billion overall ($14.5 billion in the US civilian population ...
[202]
[PDF] Evaluating PTSD Claims in Minnesota's Workers' Compensation ...
Aug 1, 2025 · were specific to individual state or federal workers' compensation jurisdictions. ... differences in PTSD claim approval rates, legal ...Missing: litigious | Show results with:litigious
[203]
Research: Compensating Workers for Permanent Partial Disabilities
There is substantial variability in how state workers' compensation laws provide benefits to workers who have a permanent partial disability.Missing: PTSD | Show results with:PTSD
[204]
Impacts of the 2010 VA PTSD Rule Change on Participation in SSA ...
May 16, 2022 · We studied a 2010 DC rule change that made it easier for veterans with posttraumatic stress disorder to demonstrate eligibility.<|control11|><|separator|>
[205]
Exploring Biomarker Technology to Enhance the Diagnosis and ...
Identifying reliable biomarkers may mitigate common PTSD diagnostic and treatment issues, moving diagnosis and treatment away from self-reported symptoms.Missing: moral | Show results with:moral
[206]
MVP study reveals new markers of genetic risk for PTSD
Feb 24, 2021 · A large VA Million Veteran Program study found new genetic markers for posttraumatic stress disorder risk.
[207]
Proposed Changes to the Department of Veterans Affairs Disability ...
Jun 1, 2023 · The VA recently proposed sweeping changes to the rating rubric for mental disorders ... Stress Disorders, Post-Traumatic* / diagnosis; Stress ...

PTS